missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TAZ Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
€ 185.00 - € 393.00
Specifications
| Antigen | TAZ |
|---|---|
| Concentration | 0.5 mg/mL |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Western Blot |
| Classification | Polyclonal |
| Conjugate | Unconjugated |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
17940683
|
Invitrogen™
PA5145369 |
200 μL |
€ 393.00
200µL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
17929322
|
Invitrogen™
PA5145370 |
20 μL |
€ 185.00
20µL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy, hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction. Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.Specifications
| TAZ | |
| Immunohistochemistry (Paraffin), Western Blot, Western Blot | |
| Unconjugated | |
| Rabbit | |
| Human, Mouse | |
| Q16635 | |
| 66826, 6901 | |
| Recombinant Human TAZ protein, Gly154-Arg292 (Accession #Q16635). | |
| Primary | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| 0.5 mg/mL | |
| Polyclonal | |
| Liquid | |
| RUO | |
| PBS with 50% glycerol and 0.05% Proclin 300; pH 7.4 | |
| 2310058J06Rik; 2610021I22Rik; 5031411C02Rik; 9130012G04Rik; AW107266; AW552613; Barth syndrome); BTHS; C78399; cardiomyopathy, dilated 3A (X-linked); CMD3A; EFE; EFE2; endocardial fibroelastosis 2; FLJ27390; G4.5; HGNC:11577; LVNCX; OTTHUMP00000061673; protein G4.5; Tafazzin; tafazzin (cardiomyopathy, dilated 3A (X-linked); tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome); Taz; Taz1; transcriptional coactivator with PDZ binding motif; transcriptional co-activator with PDZ-binding motif; transcriptional coactivator with PDZ-binding motif; transcriptional co-activator with PDZ-binding motif (TA)Z; transcriptional co-activator with PDZ-binding motif (TAZ); WW domain containing transcription regulator 1; WW domain-containing transcription regulator protein 1; Wwtr1; XAP-2; XX-FW83563B9.3 | |
| TAZ | |
| IgG | |
| Antigen affinity chromatography, Protein A | |
| TAZ |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title